Article
Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice.
Blood - 11 May 2017
García-Ramírez Idoia, Tadros Saber, González-Herrero Inés, Martín-Lorenzo Alberto, Rodríguez-Hernández Guillermo, Moore Dalia, Ruiz-Roca Lucía, Blanco Oscar, Alonso-López Diego, Rivas Javier De Las, Hartert Keenan, Duval Romain, Klinkebiel David, Bast Martin, Vose Julie, Lunning Matthew, Fu Kai, Greiner Timothy, Rodrigues-Lima Fernando, Jiménez Rafael, Criado Francisco Javier García, Cenador María Begoña García, Brindle Paul, Vicente-Dueñas Carolina, Alizadeh Ash, Sánchez-García Isidro, Green Michael R
Abstract excerpt
CREBBP is targeted by inactivating mutations in follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL). Here, we provide evidence from transgenic mouse models that Crebbp deletion results in deficits in B-cell development and can cooperate with Bcl2 overexpression to promote B-cell lymphoma. Through transcriptional and epigenetic profiling of these B cells, we found that Crebbp inactivation was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
